Massimo Masiero
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Developmental Biology and Gene Regulation 5
- Cancer-related gene regulation 3
- Kruppel-like factors research 2
- Histone Deacetylase Inhibitors Research 2
-
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Stefano Indraccolo (8 shared papers)Elena Favaro (3 shared papers)Alison H. Banham (6 shared papers)Luca Persano (5 shared papers)Lidia Moserle (5 shared papers)Alberto Amadori (5 shared papers)Sonia Minuzzo (4 shared papers)Giorgia Nardo (2 shared papers)
- Journals
- Cancer Research (3 papers)Molecular Cancer Therapeutics (1 paper)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)Molecular Aspects of Medicine (1 paper)Leukemia (1 paper)
- Partner nations
- ItalyUnited KingdomGermany
In The Last Decade
Massimo Masiero
23 papers receiving 789 citations
Peers
Comparison fields: 5 of 94
- Cancer Research 192
- Nephrology 56
- Hematology 78
- Genetics 70
- Molecular Biology 405
Countries citing papers authored by Massimo Masiero
This map shows the geographic impact of Massimo Masiero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Masiero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Masiero more than expected).
Fields of papers citing papers by Massimo Masiero
This network shows the impact of papers produced by Massimo Masiero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Masiero. The network helps show where Massimo Masiero may publish in the future.
Co-authors
The 25 scholars most cited alongside Massimo Masiero, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 117 | |
| 2 | 1998 | 116 | |
| 3 | 2011 | 76 | |
| 4 | 2016 | 59 | |
| 5 | 2007 | 53 | |
| 6 | 2011 | 46 | |
| 7 | 1990 | 45 | |
| 8 | 2014 | 42 | |
| 9 | 2008 | 38 | |
| 10 | 2007 | 35 | |
| 11 | 1990 | 33 | |
| 12 | 2019 | 31 | |
| 13 | 2014 | 28 | |
| 14 | 2013 | 24 | |
| 15 | 2020 | 18 | |
| 16 | 2010 | 15 | |
| 17 | 2022 | 9 | |
| 18 | 2021 | 7 | |
| 19 | 2022 | 4 | |
| 20 | 1990 | 4 |
About Massimo Masiero
Massimo Masiero is a scholar working on Molecular Biology, Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 23 papers that have together received 806 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Developmental Biology and Gene Regulation (5 papers), Cancer-related gene regulation (3 papers), Kruppel-like factors research (2 papers), Ultrasound and Cavitation Phenomena (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Ultrasound and Hyperthermia Applications (2 papers) and Infectious Diseases and Mycology (2 papers). The work is most often cited by research in Cancer Research (192 citations), Nephrology (56 citations), Hematology (78 citations), Genetics (70 citations) and Molecular Biology (405 citations). Massimo Masiero has collaborated with scholars based in Italy, United Kingdom and Germany. Frequent co-authors include Stefano Indraccolo, Elena Favaro, Alison H. Banham, Luca Persano, Lidia Moserle, Alberto Amadori, Sonia Minuzzo, Giorgia Nardo, Irene Pusceddu and Adrian L. Harris. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Clinical Chemistry and Laboratory Medicine (CCLM), Molecular Aspects of Medicine and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.